Philip Kim & Aldeyra Therapeutics

Philip Kim: Philip Kim is an attorney at Rosen Law Firm, providing information and assistance to investors regarding the Aldeyra Therapeutics class action.

Aldeyra Therapeutics: Aldeyra Therapeutics is the primary defendant in multiple class action lawsuits filed by various law firms, alleging that the company made false and misleading statements regarding the clinical trials of its drug candidate, reproxalap. The company's stock price fell significantly after the United States — Food and Drug Administration issued a Complete Response Letter for reproxalap.